CBA
CAPR icon

Coastal Bridge Advisors’s Capricor Therapeutics CAPR Stock Holding History

Coastal Bridge Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,000
Closed -$130K – 465
2025
Q3 		$130K Buy
+18,000
New +$133K 0.01% 447

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Coastal Bridge Advisors's CAPR Position: Q4 2025 in Review

Coastal Bridge Advisors sold out of Capricor Therapeutics (CAPR) in Q4 2025, closing a stake of 10,894 shares — an estimated $78.5K sold.

Coastal Bridge Advisors first reported a position in CAPR in Q4 2015 and held it in 40 quarters. The position peaked at $489K in Q1 2017. 132 funds tracked by Wall St. Rank hold CAPR as of Q4 2025.

  • Coastal Bridge Advisors reported no remaining Capricor Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Coastal Bridge Advisors sold 10,894 Capricor Therapeutics shares in Q4 2025, an estimated $78.5K.
  • Coastal Bridge Advisors first reported a position in Capricor Therapeutics in Q4 2015 and held it in 40 quarters.
  • Coastal Bridge Advisors's Capricor Therapeutics position peaked at $489K in Q1 2017.
  • 132 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2025.

Based on Coastal Bridge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.